Parallel Advisors, LLC Sanofi Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, Parallel Advisors, LLC holds 8,751 shares of SNY stock, worth $475,529. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,751
Previous 7,732 13.18%
Holding current value
$475,529
Previous $375,000 34.4%
% of portfolio
0.01%
Previous 0.01%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$48.54 - $58.53 $49,462 - $59,642
1,019 Added 13.18%
8,751 $504,000
Q2 2024

Aug 08, 2024
BUY
$45.39 - $50.36 $44,799 - $49,705
987 Added 14.63%
7,732 $375,000
Q1 2024

May 06, 2024
BUY
$45.75 - $52.48 $55,540 - $63,710
1,214 Added 21.95%
6,745 $327,000
Q4 2023

Feb 09, 2024
SELL
$43.13 - $54.79 $43,518 - $55,283
-1,009 Reduced 15.43%
5,531 $275,000
Q3 2023

May 20, 2024
BUY
$50.95 - $55.2 $46,262 - $50,121
908 Added 16.12%
6,540 $350,000
Q3 2023

Nov 13, 2023
BUY
$50.95 - $55.2 $46,262 - $50,121
908 Added 16.12%
6,540 $350,000
Q2 2023

May 20, 2024
BUY
$50.45 - $57.18 $22,500 - $25,502
446 Added 8.6%
5,632 $303,000
Q2 2023

Aug 04, 2023
BUY
$50.45 - $57.18 $22,500 - $25,502
446 Added 8.6%
5,632 $303,000
Q1 2023

May 20, 2024
SELL
$45.86 - $54.45 $71,495 - $84,887
-1,559 Reduced 23.11%
5,186 $282,000
Q1 2023

Apr 25, 2023
BUY
$45.86 - $54.45 $37,834 - $44,921
825 Added 18.92%
5,186 $282,000
Q4 2022

Feb 03, 2023
SELL
$38.86 - $48.55 $75,077 - $93,798
-1,932 Reduced 30.7%
4,361 $211,000
Q3 2022

Nov 10, 2022
SELL
$37.22 - $100.5 $102,913 - $277,882
-2,765 Reduced 30.53%
6,293 $239,000
Q2 2022

Aug 01, 2022
BUY
$48.99 - $57.46 $24,446 - $28,672
499 Added 5.83%
9,058 $453,000
Q1 2022

Apr 28, 2022
BUY
$48.48 - $53.65 $5,041 - $5,579
104 Added 1.23%
8,559 $442,000
Q4 2021

Jan 20, 2022
BUY
$47.07 - $52.35 $12,285 - $13,663
261 Added 3.19%
8,455 $424,000
Q3 2021

Nov 02, 2021
BUY
$47.89 - $53.12 $8,907 - $9,880
186 Added 2.32%
8,194 $395,000
Q2 2021

Aug 06, 2021
BUY
$49.36 - $54.25 $23,297 - $25,606
472 Added 6.26%
8,008 $422,000
Q1 2021

Apr 23, 2021
SELL
$45.46 - $50.51 $500 - $555
-11 Reduced 0.15%
7,536 $373,000
Q4 2020

Feb 02, 2021
SELL
$45.3 - $51.62 $17,168 - $19,563
-379 Reduced 4.78%
7,547 $367,000
Q3 2020

Oct 27, 2020
BUY
$49.47 - $53.77 $5,936 - $6,452
120 Added 1.54%
7,926 $398,000
Q2 2020

Jul 16, 2020
BUY
$42.91 - $52.5 $10,684 - $13,072
249 Added 3.29%
7,806 $398,000
Q1 2020

Apr 27, 2020
BUY
$38.02 - $51.66 $55,965 - $76,043
1,472 Added 24.19%
7,557 $330,000
Q4 2019

Jan 30, 2020
SELL
$44.25 - $50.86 $26,373 - $30,312
-596 Reduced 8.92%
6,085 $305,000
Q3 2019

Nov 01, 2019
BUY
$40.34 - $46.64 $90,159 - $104,240
2,235 Added 50.27%
6,681 $310,000
Q2 2019

Aug 05, 2019
BUY
$40.43 - $44.3 $42,208 - $46,249
1,044 Added 30.69%
4,446 $192,000
Q1 2019

May 01, 2019
BUY
$40.83 - $45.43 $67,042 - $74,596
1,642 Added 93.3%
3,402 $151,000
Q4 2018

Feb 05, 2019
BUY
$41.48 - $45.59 $23,726 - $26,077
572 Added 48.15%
1,760 $76,000
Q3 2018

Nov 01, 2018
BUY
$40.0 - $44.84 $10,280 - $11,523
257 Added 27.6%
1,188 $53,000
Q2 2018

Jul 30, 2018
SELL
$37.63 - $41.22 $10,536 - $11,541
-280 Reduced 23.12%
931 $37,000
Q1 2018

May 08, 2018
SELL
$38.98 - $45.76 $31,456 - $36,928
-807 Reduced 39.99%
1,211 $49,000
Q4 2017

Feb 13, 2018
SELL
$42.86 - $50.61 $55,760 - $65,843
-1,301 Reduced 39.2%
2,018 $87,000
Q3 2017

Nov 15, 2017
BUY
$47.04 - $50.34 $156,125 - $167,078
3,319 New
3,319 $148,000
Q3 2017

Nov 14, 2017
SELL
$47.04 - $50.34 $138,015 - $147,697
-2,934 Closed
0 $0
Q2 2017

Aug 07, 2017
BUY
N/A
2,934
2,934 $139,000

Others Institutions Holding SNY

# of Institutions
810
Shares Held
267M
Call Options Held
2M
Put Options Held
1.9M
View Full List

About Sanofi

SNY Quotes by TradingView
  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $136B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email